Table 2 Change in eosinophil tear number (n/µl).
| Eosinophil tear no. (n/µL) | ||||
|---|---|---|---|---|
| Visits | NAAGA (n = 10*) | LEVO (n = 10*) | ||
| Mean (SD | Median (quartiles) | Mean (SD) | Median (quartiles) | |
| D0 | 23.5 (15.6) | 21.0 (15.0; 27.0) | 16.3 (12.1) | 11.0 (7.0; 22.5) |
| D7 | 15.0 (12.5) | 10.0 (5.0; 28.0) | 12.3 (8.1) | 10.0 (7.5; 18.0) |
| D28 | 5.8 (4.4) | 4.0 (3.0; 10.0) | 11.7 (8.7) | 7.0 (5.0; 23.0) |
| Treatment effect†; 95% CI | p value† | |||
|---|---|---|---|---|
| D7–D0 | −2.0 (−11.0; 7.0) | 0.593 | ||
| D28–D0 | −11.0 (−23.0; 1.0) | 0.064 | ||
| Both visits–D0 | −6.3 (−14.5; 5.0) | 0.186 |
*Naaga group: day 0 n = 10, day 7 n = 9 and day 28 n = 8. Levo group: day 0 n = 10; day 7 n = 9 and day 28 n = 9; †Hodges–Lehmann semiparametric estimate and Wilcoxon test p value.